Skip to Content

Lundbeck Encourages Epilepsy Community to Attend Upcoming Partners Against Mortality in Epilepsy (PAME) Conference

First Ever Conference on Sudden Unexpected Death in Epilepsy for Professionals and Patients

DEERFIELD, Ill.--(BUSINESS WIRE)--Jun 8, 2012 - Lundbeck is proud to support the first Partners Against Mortality in Epilepsy (PAME) conference taking place at the Hilton Orrington in Evanston, IL, a suburb of Chicago, June 21-24, 2012. The conference will include discussions around Sudden Unexpected Death in Epilepsy (SUDEP), a condition that may occur suddenly and unexpectedly among epilepsy patients, most frequently those who experience chronic epilepsy.1 Healthcare professionals, patients, families and caregivers can register to attend PAME at

Interest in SUDEP, the most common cause of death directly related to epilepsy, has recently increased among clinical and basic scientists as well as patients, their families and advocacy organizations.2,3 The conference, organized by a coalition of advocacy and professional organizations related to epilepsy, is the first to bring together healthcare professionals, patients, families and caregivers to discuss this vitally important topic. Members of the professional and patient community can attend PAME to discover new research findings, hear about risk factors and learn how to employ prevention techniques.

“SUDEP is a frightening possibility that needs to be addressed, and thankfully growing interest from the clinical and basic sciences is opening up doors for valuable discussion. Our hope is that by having physicians, advocacy groups and patients come together as a community to discuss SUDEP, we will be able to work toward better patient care,” said Jeffrey D. Melin, M.Ed., CMP, director of education at the American Epilepsy Society. “We appreciate Lundbeck's commitment to the epilepsy community and the important conversations that will take place at PAME.”

“Lundbeck is proud to support this landmark conference,” said Daniel Brennan, vice president of neurology at Lundbeck. “We applaud the PAME Coalition Partners for bringing this important topic to the forefront and providing education and hope to those impacted by epilepsy.”

About the Partners Against Mortality in Epilepsy (PAME) Conference

This three-day learning event is the first Partners Against Mortality in Epilepsy (PAME) conference devoted predominantly to Sudden Unexpected Death In Epilepsy (SUDEP), where healthcare professionals, patients, families and caregivers will come together to understand and support each other. This is a joint effort of SUDEP Coalition Partners, with meeting coordination and production by the American Epilepsy Society. This conference will be held June 21-24, 2012 at the Hilton Orrington in the Chicago suburb of Evanston, Illinois. To register for the conference, visit

About Lundbeck in the U.S.

Lundbeck in the U.S., headquartered in Deerfield, Illinois, is a wholly-owned subsidiary of H. Lundbeck A/S in Denmark. Lundbeck is dedicated to providing therapies that fulfill unmet medical needs of people with central nervous system (CNS) disorders.

With a special commitment to addressing the needs of the epilepsy community, Lundbeck invests millions annually in epilepsy research and medical education. Lundbeck also partners with professional and advocacy organizations to support and expand important programs for people with epilepsy, such as Studio E: The Epilepsy Art Therapy Program. Learn more at

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improving the quality of life for people suffering from brain disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at disorders such as depression and anxiety, schizophrenia, insomnia, epilepsy, Huntington's, Alzheimer's and Parkinson's diseases. Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with brain disorders. In 2011, the company's revenue was DKK 16.0 billion (approximately EUR 2.2 billion or USD 3.0 billion). For more information, please visit



  1. Surges, R. et al. Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms. Nat. Rev Neurol. 2009 September; 5, 492–504.
  2. Buchhalter, J. Contemporary Topics in Epilepsy Care: SUDEP. December 15, 2011. Last accessed 6/6/12.
  3. PAME Conference Website. Partners. American Epilepsy Society. SUDEP History & Background. Last accessed 6/6/2012.

Contact: Lundbeck
Matt Flesch
(847) 282-1154



Posted: June 2012